SAN2_FUSV7
ID SAN2_FUSV7 Reviewed; 370 AA.
AC C7ZBE5;
DT 12-AUG-2020, integrated into UniProtKB/Swiss-Prot.
DT 13-OCT-2009, sequence version 1.
DT 03-AUG-2022, entry version 56.
DE RecName: Full=Aldo-keto reductase NECHADRAFT_45914 {ECO:0000303|PubMed:26936154};
DE EC=1.1.1.- {ECO:0000305|PubMed:26936154};
DE AltName: Full=Sansalvamide biosynthesis cluster protein NECHADRAFT_45914 {ECO:0000303|PubMed:26936154};
GN ORFNames=NECHADRAFT_45914;
OS Fusarium vanettenii (strain ATCC MYA-4622 / CBS 123669 / FGSC 9596 / NRRL
OS 45880 / 77-13-4) (Fusarium solani subsp. pisi).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;
OC Hypocreomycetidae; Hypocreales; Nectriaceae; Fusarium;
OC Fusarium solani species complex; Fusarium vanettenii.
OX NCBI_TaxID=660122;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC MYA-4622 / CBS 123669 / FGSC 9596 / NRRL 45880 / 77-13-4;
RX PubMed=19714214; DOI=10.1371/journal.pgen.1000618;
RA Coleman J.J., Rounsley S.D., Rodriguez-Carres M., Kuo A., Wasmann C.C.,
RA Grimwood J., Schmutz J., Taga M., White G.J., Zhou S., Schwartz D.C.,
RA Freitag M., Ma L.-J., Danchin E.G.J., Henrissat B., Coutinho P.M.,
RA Nelson D.R., Straney D., Napoli C.A., Barker B.M., Gribskov M., Rep M.,
RA Kroken S., Molnar I., Rensing C., Kennell J.C., Zamora J., Farman M.L.,
RA Selker E.U., Salamov A., Shapiro H., Pangilinan J., Lindquist E.,
RA Lamers C., Grigoriev I.V., Geiser D.M., Covert S.F., Temporini E.,
RA VanEtten H.D.;
RT "The genome of Nectria haematococca: contribution of supernumerary
RT chromosomes to gene expansion.";
RL PLoS Genet. 5:E1000618-E1000618(2009).
RN [2]
RP FUNCTION, AND PATHWAY.
RX PubMed=26936154; DOI=10.1007/s00294-016-0584-4;
RA Romans-Fuertes P., Sondergaard T.E., Sandmann M.I., Wollenberg R.D.,
RA Nielsen K.F., Hansen F.T., Giese H., Brodersen D.E., Soerensen J.L.;
RT "Identification of the non-ribosomal peptide synthetase responsible for
RT biosynthesis of the potential anti-cancer drug sansalvamide in Fusarium
RT solani.";
RL Curr. Genet. 62:799-807(2016).
CC -!- FUNCTION: Aldo-keto reductase; part of the gene cluster that mediates
CC the biosynthesis of sansalvamide, a cyclic pentadepsipeptide that shows
CC promising results as potential anti-cancer drug (PubMed:26936154). The
CC nonribosmal peptide synthetase NRPS30 produces sansalvamide by
CC incorporating successively one phenylalanine, one leucine, one alpha-
CC hydroxyisocaproic acid (HICA), one valine and one leucine before
CC sansalvamide is released from by cyclization by the terminal C domain
CC of NRPS30 (PubMed:26936154). The HICA residue is probably provided by
CC reduction of alpha-ketoisocaproate by the cluster-specific aldo-keto
CC reductase (NECHADRAFT_45914) (Probable). {ECO:0000269|PubMed:26936154,
CC ECO:0000305|PubMed:26936154}.
CC -!- PATHWAY: Secondary metabolite biosynthesis.
CC {ECO:0000305|PubMed:26936154}.
CC -!- SIMILARITY: Belongs to the aldo/keto reductase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; GG698914; EEU38724.1; -; Genomic_DNA.
DR RefSeq; XP_003044437.1; XM_003044391.1.
DR AlphaFoldDB; C7ZBE5; -.
DR SMR; C7ZBE5; -.
DR STRING; 660122.C7ZBE5; -.
DR EnsemblFungi; NechaT45914; NechaP45914; NechaG45914.
DR GeneID; 9670749; -.
DR KEGG; nhe:NECHADRAFT_45914; -.
DR eggNOG; KOG1575; Eukaryota.
DR HOGENOM; CLU_023205_2_0_1; -.
DR InParanoid; C7ZBE5; -.
DR OMA; EREMIKY; -.
DR OrthoDB; 1383971at2759; -.
DR Proteomes; UP000005206; Unassembled WGS sequence.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR Gene3D; 3.20.20.100; -; 1.
DR InterPro; IPR023210; NADP_OxRdtase_dom.
DR InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR Pfam; PF00248; Aldo_ket_red; 1.
DR SUPFAM; SSF51430; SSF51430; 1.
PE 3: Inferred from homology;
KW NADP; Oxidoreductase; Reference proteome.
FT CHAIN 1..370
FT /note="Aldo-keto reductase NECHADRAFT_45914"
FT /id="PRO_0000450717"
FT ACT_SITE 83
FT /note="Proton donor"
FT /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT BINDING 78
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:O43488"
FT BINDING 174
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT BINDING 204..205
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:O43488"
FT BINDING 230
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:O43488"
FT BINDING 259..269
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:O43488"
FT BINDING 333..341
FT /ligand="NADP(+)"
FT /ligand_id="ChEBI:CHEBI:58349"
FT /evidence="ECO:0000250|UniProtKB:O43488"
SQ SEQUENCE 370 AA; 41890 MW; 03EC40A1EB31FB44 CRC64;
MSKTSVDKLL RIPQSLRDSI SRTRVDYRHL GNCGLRVSNP ILGGLHIGNS RWLPWVLNEE
DAMPILKAAY DRGINTWDTA NVYSNGESEK VIAKALRKYN IPRSKVILMT KCYRVVCDSE
NFDPGSGVTM HHELADKSKD YVNQWGLSRA AIFNAVEASL ERLGTHYIDI FQIHRFDPTV
PIAETMSALN DLVKAGMVRY LGASSMWTYQ FAAMQNLAHA KGWTKFVSMQ NHYNLIYREE
EREMIRYCND TGVGLIPWAP LASGRLARRP SQQSVSIRAS NSRNGSIYEA DDSNTDKIVS
RVEEIAVKRN WPMSHVALAW LNKRVTAPII GFSTVQRIEE ALAAVGKELS EDEERYLEEL
YAPRPIQGHS